Upcoming Medical Conferences in Coral GablesSearch Criteria : United States of America Coral Gables
An Evidence-based, Individualized Approach to the Management of Gastrointestinal Malignancies (Jul 24, 2019)
Jul 24, 2019 | Contact Ho 2.00 | Coral Gables, Florida
An Evidence-based, Individualized Approach to the Management of Gastrointestinal Malignancies is organized by Med Learning Group and will be held on Jul 24, 2019 at Hotel Colonnade Coral Gables, Coral Gables, Florida, United States of America. Target Audience: This activity is designed to meet the needs of medical oncologists, particularly community oncologists, oncology nurses, and other health care professionals involved in caring for patients with gastrointestinal cancers. Accreditation: 2.0 AMA Category 1 Credit(s)TM. 2.0 ANCC Contact Hour(s) 2.0 contact hour(s) of continuing nursing education of RNs and APNs. Description: This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use. Objectives: • Review evidence and guideline recommendations for optimally sequencing different treatment modalities across subsequent lines of therapy for advanced and metastatic gastric (GC) and gastroesophageal junction (GEJ) cancers. • Discuss strategies to individualize therapy for advanced and metastatic GC and GEJ cancers based on patient’s characteristics and biomarkers across lines of treatment. • Review the clinical evidence of the prognostic and predictive value of anatomical characteristics and biomarkers in guiding treatment selection for advanced and metastatic colorectal cancer (CRC) across lines of therapy. • Review the biology of α-fetoprotein (AFP) in hepatocellular carcinoma (HCC); explain the clinical significance of elevated serum AFP; and discuss AFP’s role as a prognostic and predictive biomarker in HCC.